The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function-Reference-Cited by-同舟云学术

The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function

Published:2018-10 Issue:1 Volume:25 Page:80-94
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Hernandez Sairy,Qing Jing,Thibodeau Rebecca Hong,Du Xiangnan,Park Summer,Lee Hyang-Mi,Xu Min,Oh Soyoung,Navarro Armando,Roose-Girma Meron,Newman Robert J.,Warming Soren,Nannini Michelle,Sampath Deepak,Kim Jeong M.,Grogan Jane L.,Mellman Ira

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference56 articles.

1. PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction;Abiko;Clin. Cancer Res.,2013

2. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer;Abiko;Br. J. Cancer,2015

3. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence;Ahmed;J. Exp. Med.,1984

4. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation;Alzabin;J. Immunol.,2009

5. Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response;Alzabin;Cancer Immunol. Immunother.,2010

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1;ACS Medicinal Chemistry Letters;2024-09-03

2. Small-molecule in cancer immunotherapy: Revolutionizing cancer treatment with transformative, game-changing breakthroughs;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Design, synthesis, and biological evaluation of novel HPK1 inhibitors possessing 3-cyano-quinoline moiety;Bioorganic Chemistry;2024-09

4. Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy;Journal of Medicinal Chemistry;2024-07-31

5. Design, synthesis, and biological evaluation of 2,4-diaminopyrimidine derivatives as potent Hematopoietic Progenitor Kinase 1 (HPK1) inhibitors;Bioorganic Chemistry;2024-07